Sysmex

Skip Navigation

SearchMenu

About Sysmex

Press Release

▼ Old News

2017rss

Oct. 16, 2017 Research & Development Research & Development
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
Oct. 12, 2017 Products & Solution Products & Solution
Insurance Coverage of Lymph Node Metastasis Testing for Non-Small-Cell Lung Cancer Using the OSNA™ Method
Oct. 02, 2017 Other Other
Sysmex Signs Affiliation Agreements with Figure Skaters Mai Mihara and Kaori Sakamoto
-Supporting the Efforts of Athletes from Kobe as They Take up Challenges on the World Stage-
Sep. 26, 2017 Products & Solution Products & Solution
Sysmex Launches the Revohem FVIII Chromogenic, a Coagulation Factor VIII Assay Reagent
-Helping to Diagnose and Assist in Treatment of Hemophilia A-
Sep. 19, 2017 Products & Solution Products & Solution
Sysmex Signs Agreement with Mongolia’s Ministry of Health to Provide External Quality Assessment Support in the Field of Blood Morphology Testing
Sep. 13, 2017 Management & Business Management & Business
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year
Sep. 05, 2017 Management & Business Management & Business
Sysmex Begins Conducting Direct Sales and Services in Ghana
Aug. 17, 2017 Products & Solution Products & Solution
Sysmex to Commence Sales of “Revohem PT” Reagent for Measuring Prothrombin Time, a Key Testing Parameter for Monitoring Anticoagulation Therapy
-First Japanese PT Reagent Using Recombinant Protein Mass Produced by Silkworms-
Aug. 10, 2017 Other Other
Sysmex, Hyogo Pharmaceutical Society and Shinkai Transport Systems Enter Agreement to Cooperate on Disaster Relief Activities
-Creating a System for Operating Mobile Pharmacies as a Disaster Response Measure-
Aug. 04, 2017 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2018 (PDF:725KB)
Jul. 31, 2017 Management & Business Management & Business
Sysmex Completes Expansion of Reagent Factory in the United States
-Reagent Production Capacity Boosted to 1.8 Times Former Level in Line with Expected Increase in Demand in the Americas-
Jul. 27, 2017 Management & Business Management & Business
Sysmex and bioMérieux Agreed to Dissolve the Joint Venture Sysmex bioMérieux Co., Ltd.
Jun. 28, 2017 Management & Business Management & Business
Our Views and Policy regarding Investment Unit Reduction (PDF:26KB)
Jun. 27, 2017 Products & Solution Products & Solution
Sysmex Expands XN-Series Product Lineup in the Hematology Field
-Achieving Further Productivity Improvements in Hematology Testing Through Footprint Reduction-
Jun. 05, 2017 Management & Business Management & Business
Sysmex, RIKEN GENESIS and MKI Sign Comprehensive Collaboration Agreement with a View to Joint Promotion of Genomic Medicine
Jun. 01, 2017 Management & Business Management & Business
Sysmex Continuing to Participate in the Global Health Innovative Technology Fund
Jun. 01, 2017 Research & Development Research & Development
Sysmex Opens New R&D Facility with a View toward the Realization of Personalized Medicine
May. 31, 2017 Management & Business Management & Business
Sysmex Acquires UK Company to Expand into New Business Domains toward Personalized Medicine
-Expanding Our Portfolio and Reinforcing Our Technology Base in the Life Science Business-
May. 25, 2017 Research & Development Research & Development
Sysmex Receives Invention Award in the 2017 National Commendation for Invention
May. 15, 2017 Products & Solution Products & Solution
Sysmex to Launch the Semi-Automated Urine Chemistry Analyzer UC-1000, a Compact Model in the Field of Urine Qualitative Analysis, in Overseas Markets
May. 10, 2017 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2017 (PDF:286KB)
May. 10, 2017 Investor Relations Investor Relations
Sysmex Announces Changes from Financial Results Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2017 (PDF:82KB)
May. 10, 2017 Management & Business Management & Business
Sysmex Announces New Group Mid-Term Management Plan
- Accelerating the Speed of Execution to Realize Sustainable Growth Going Forward - (PDF:119KB)
May. 10, 2017 Management & Business Management & Business
Announcement of Executive Change (PDF:53KB)
Apr. 11, 2017 Research & Development Research & Development
Sysmex Receives the Fiscal 2017 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (Prize for Science and Technology)
Apr. 06, 2017 Research & Development Research & Development
RIKEN GENESIS Establishes RIKEN GENESIS Innovation Genome Center to Provide Lab-Assay Services for Genetic Testing
Apr. 03, 2017 Management & Business Management & Business
Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities
Apr. 02, 2017 Management & Business Management & Business
Establishment of Funded Courses at the Kobe University Graduate School of Medicine
-Encouraging Leading-Edge Cancer Research through Department of International Clinical Cancer Research-
Mar. 29, 2017 Other Other
Sysmex to Be Special Sponsor of the Kobe Marathon 2017
-We are pleased to have sponsored this exciting event since its inception in 2011-
Mar. 28, 2017 Products & Solution Products & Solution
Medicaroid Launches the SOT-100 Vercia, Operating Table with the Function to Move Patients Widely
Mar. 06, 2017 Management & Business Management & Business
Announcement of Organizational and Personnel Changes (PDF:449KB)
Mar. 01, 2017 Research & Development Research & Development
Cancer-Related Gene Panel Testing System Designated Under the Ministry of Health, Labour and Welfare’s Sakigake Designation System
Feb. 24, 2017 Other Other
FY2016 Nakatani Award and Research Grant Recipients Announced (PDF:216KB)
Feb. 09, 2017 Research & Development Research & Development
Sysmex Enters into Research Collaboration Agreement in Relation to Cancer and Rare Diseases with the University of Tokyo
-Aiming for the Clinical Application of Genomic Medicine-
Feb. 03, 2017 Investor Relations Investor Relations
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2017 (PDF:329KB)
Feb. 03, 2017 Management & Business Management & Business
Reinforcing the Sales and Service Structure in Taiwan
Transitioning to a Direct Sales and Service Structure through the Transfer of Business from a Distributor
Jan. 20, 2017 Management & Business Management & Business
Sysmex Selected as One of 2017 Global 100’s Most Sustainable Companies in the World
Back to "About Sysmex"